Clinical Trials on Gentamicin Ototoxicity in Denmark
Total 1 results
-
University of AarhusMartin TolstrupEnrolling by invitationHealthy | Cytotoxicity | Yellow Fever Vaccination ReactionDenmark
Sponsors and Collaborators
- REDNVIA Co., Ltd.
- Kingston Hospital NHS Trust
- Hospital Central de San Isidro Dr. Melchor Angel Posse
- Dawn Smiley MD
- Natalis Counseling Center
- Ningbo Medical Center Lihuili Eastern Hospital
- Luiz Aparecido Bortolotto
- Sinomune Pharmaceutical Co., Ltd
- Heba Mitwalli
- Dr. med. Christian Rothermundt
- Instituto National de Edfermedades Neoplasicas
- Johan Sanmartin Berglund
- Healthy African American Families II
- Adial Pharmaceuticals
- American Association of Critical Care Nursing
- Hospital Clinico Universitario de Santiago
- Shu Mei Kato
- Laboratoire de la Mer
- Kyowa Hakko Bio Co., Ltd.
- Progenics Pharmaceuticals, Inc.
- View Full List
Medical Conditions
- Autosomal Dominant Hypocalcaemia
- Open Reduction and Internal Fixation
- HIV Related Insulin Resistance
- Refractory Transformed B-Cell Non-Hodgkin Lymphoma
- Insulin-Dependent Diabetes Mellitus
- Acute Myocardial Infarction, of Inferolateral Wall
- Incompetence, Functional
- Asian Consortium
- Subgluteal Sciatic Block
- Surgery Induced Tissue Adhesions
- Ovarian Aging
- Sepsis and Coagulopathy
- Community-Acquired Staphylococcus Aureus
- Colonic Adenoma
- Neovascular Age-related Macular Degeneration(nAMD)
- Sensory Reconstruction of Digits
- Oxidative Stress in Patient With Haemoglobinopathy and Affect it of Endocrine System
- Robot-assisted Laparoscopic Prostatectomy Under General Anesthesia
- Reduction, Weight
- UP in Online Group Format
- View Full List
Drug Interventions
- BI 207127
- Teniposide
- Sintilimab
- Antiplatelet Drug (Aspirin or Statin)
- Trastuzumab deruxtecan (T-DXd) with pyrotinib
- Finasteride
- CKD-501 and D759
- Naproxen
- Apatinib Mesylate
- Endocrine Therapy
- PERSERIS
- REGN3500
- Janssen Ad26.COV2.S
- Acalabrutinib in combination with VR
- Pembrolizumab
- Probiotic
- Carboplatin
- Insulin-like growth factor I
- Standard treatment+mirabegron
- 0.9% NS + AT
- View Full List
CROs by country
- Contract Research Organizations in Benin
- Contract Research Organizations in Costa Rica
- Contract Research Organizations in Estonia
- Contract Research Organizations in Finland
- Contract Research Organizations in Ghana
- Contract Research Organizations in Hong Kong
- Contract Research Organizations in Israel
- Contract Research Organizations in Liberia
- Contract Research Organizations in Pakistan
- Contract Research Organizations in Qatar
- Contract Research Organizations in Spain
- Contract Research Organizations in Sri Lanka
- Contract Research Organizations in Togo
- CRO list by country